MAXIMUM STRENGTH MEDICATED FOOT POWDER TALC FREE

MAXIMUM STRENGTH MEDICATED FOOT POWDER TALC FREE was reported 1035 times

MAXIMUM STRENGTH MEDICATED FOOT POWDER TALC FREE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 URTICARIA THERMAL 20 0.1408
1 HERNIA DIAPHRAGMATIC REPAIR 1 0.0909
2 NAIL BED TENDERNESS 8 0.0702
3 ADMINISTRATION SITE ERYTHEMA 14 0.0491
4 COLONIC HAEMATOMA 3 0.0353
5 EPITHELIOID MESOTHELIOMA 9 0.0256
6 BIPHASIC MESOTHELIOMA 1 0.0233
7 DRESSLER'S SYNDROME 1 0.0227
8 CYCLIC NEUTROPENIA 1 0.0192
9 CHEMICAL INJURY 13 0.0159
10 PERITONEAL MESOTHELIOMA MALIGNANT 3 0.0155
11 NASAL FLARING 2 0.0148
12 LEFT VENTRICULAR OUTFLOW TRACT GRADIENT INCREASED 1 0.0147
13 CARDIOACTIVE DRUG LEVEL DECREASED 2 0.0117
14 PROCEDURAL HYPERTENSION 2 0.0106
15 PLEURAL MESOTHELIOMA MALIGNANT 3 0.0097
16 ANAL POLYP 1 0.0097
17 LICE INFESTATION 2 0.0095
18 ANAL EROSION 1 0.0091
19 OVERLAP SYNDROME 6 0.0086
20 DERMATOPHYTOSIS OF NAIL 1 0.0084
21 ABDOMINAL WALL CYST 1 0.0082
22 IMMOBILISATION PROLONGED 1 0.0082
23 AUTONOMIC NEUROPATHY 8 0.0079
24 DENTURE WEARER 2 0.0077
25 C-REACTIVE PROTEIN 7 0.0076
26 ORTHOSIS USER 2 0.0071
27 OCCUPATIONAL EXPOSURE TO TOXIC AGENT 2 0.0070
28 BURNS FIRST DEGREE 2 0.0070
29 ELECTROCARDIOGRAM QT INTERVAL 1 0.0069
30 HEPATIC ENZYME 1 0.0067
31 LUPUS VULGARIS 8 0.0063
32 BACTERIAL TRANSLOCATION 2 0.0063
33 EYELID BLEEDING 1 0.0058
34 CHRONIC RESPIRATORY DISEASE 2 0.0057
35 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 6 0.0056
36 FRACTIONAL EXHALED NITRIC OXIDE INCREASED 1 0.0056
37 APPLICATION SITE HAEMATOMA 1 0.0055
38 ACCELERATED HYPERTENSION 2 0.0053
39 HEPATIC VASCULAR THROMBOSIS 1 0.0052
40 ANTICHOLINERGIC SYNDROME 8 0.0050
41 REPRODUCTIVE TRACT DISORDER 2 0.0050
42 VITAMIN B12 DEFICIENCY 20 0.0049
43 GREATER TROCHANTERIC PAIN SYNDROME 1 0.0049
44 BURNS THIRD DEGREE 5 0.0047
45 ADULT FAILURE TO THRIVE 1 0.0047
46 BONE SCAN ABNORMAL 2 0.0047
47 HYPERCHOLESTEROLAEMIA 44 0.0046
48 DEEP VEIN THROMBOSIS POSTOPERATIVE 9 0.0045
49 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 3 0.0045
50 DOPAMINE DYSREGULATION SYNDROME 2 0.0045
51 GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY 1 0.0043
52 METAPLASIA 2 0.0042
53 DRAINAGE 2 0.0041
54 HYPERPARATHYROIDISM SECONDARY 10 0.0040
55 EXPOSURE TO CHEMICAL POLLUTION 6 0.0036
56 CARBUNCLE 1 0.0035
57 AGONAL RESPIRATION 1 0.0035
58 HUMAN HERPESVIRUS 6 ENCEPHALITIS 1 0.0035
59 RETINITIS 6 0.0035
60 NASAL MUCOSAL DISORDER 2 0.0034
61 BURNS SECOND DEGREE 6 0.0034
62 ENTEROCOLITIS VIRAL 1 0.0033
63 VULVOVAGINAL SWELLING 6 0.0033
64 PIGMENTATION DISORDER 20 0.0032
65 HEPATIC ISCHAEMIA 1 0.0032
66 ADNEXAL TORSION 1 0.0032
67 BLOOD CHLORIDE DECREASED 8 0.0031
68 COLORECTAL ADENOMA 1 0.0031
69 CENTRAL SLEEP APNOEA SYNDROME 1 0.0031
70 JOINT DISLOCATION 31 0.0029
71 SWOLLEN JOINT COUNT INCREASED 9 0.0028
72 BLADDER TRANSITIONAL CELL CARCINOMA 4 0.0028
73 COMPLICATIONS OF BONE MARROW TRANSPLANT 1 0.0028
74 OBSTRUCTIVE SLEEP APNOEA SYNDROME 4 0.0027
75 RHEUMATIC FEVER 12 0.0027
76 GASTROINTESTINAL VASCULAR MALFORMATION HAEMORRHAGIC 1 0.0027
77 MICROALBUMINURIA 2 0.0026
78 APPLICATION SITE BURN 13 0.0026
79 HYDROURETER 1 0.0026
80 NEPHROGENIC ANAEMIA 12 0.0026
81 CONGENITAL DIAPHRAGMATIC HERNIA 1 0.0026
82 RESPIRATORY SYNCYTIAL VIRUS BRONCHIOLITIS 2 0.0026
83 BRAIN COMPRESSION 1 0.0025
84 GENITAL ABSCESS 1 0.0025
85 HIGH RISK PREGNANCY 1 0.0025
86 DERMATITIS EXFOLIATIVE 12 0.0024
87 LABYRINTHITIS 6 0.0024
88 SKIN PLAQUE 20 0.0024
89 DIVORCED 1 0.0023
90 HOMELESS 1 0.0022
91 PRIMARY SEQUESTRUM 2 0.0022
92 BIOPSY BONE MARROW ABNORMAL 1 0.0022
93 CLONUS 6 0.0022
94 ALLERGY TO PLANTS 1 0.0022
95 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 2 0.0022
96 URINARY TRACT INFECTION ENTEROCOCCAL 2 0.0021
97 ACTINOMYCOSIS 2 0.0021
98 COMA SCALE ABNORMAL 6 0.0021
99 DIZZINESS POSTURAL 20 0.0021
100 HELICOBACTER INFECTION 21 0.0020
101 SECRETION DISCHARGE 25 0.0020
102 HAEMANGIOMA OF LIVER 2 0.0020
103 BONE EROSION 7 0.0020
104 JOINT RANGE OF MOTION DECREASED 26 0.0019
105 BLOOD ALBUMIN ABNORMAL 1 0.0019
106 SCRATCH 20 0.0019
107 ASPARTATE AMINOTRANSFERASE DECREASED 1 0.0019
108 NEUROMYOPATHY 2 0.0019
109 HYPERTENSIVE NEPHROPATHY 2 0.0019
110 TRAUMATIC HAEMATOMA 2 0.0019
111 HIP ARTHROPLASTY 28 0.0018
112 PLEURITIC PAIN 5 0.0018
113 TEMPERATURE REGULATION DISORDER 4 0.0018
114 ENCEPHALOMALACIA 1 0.0018
115 BACTERIURIA 1 0.0018
116 SERONEGATIVE ARTHRITIS 2 0.0017
117 CHEMICAL BURN 2 0.0017
118 RHEUMATOID FACTOR POSITIVE 10 0.0017
119 THERMAL BURN 12 0.0017
120 ACIDOSIS HYPERCHLORAEMIC 1 0.0017
121 HYPERTENSIVE ENCEPHALOPATHY 1 0.0017
122 IRRITABLE BOWEL SYNDROME 36 0.0017
123 HEPATORENAL FAILURE 1 0.0017
124 RECTAL CANCER 5 0.0016
125 DUODENAL ULCER PERFORATION 12 0.0016
126 HYPERCHLORAEMIA 1 0.0016
127 ADRENOCORTICAL INSUFFICIENCY ACUTE 3 0.0015
128 PERSONALITY DISORDER 4 0.0015
129 GINGIVAL DISCOMFORT 1 0.0015
130 LICHEN SCLEROSUS 1 0.0015
131 ABSCESS ORAL 2 0.0015
132 MUSCLE INJURY 12 0.0014
133 AUTOIMMUNE DISORDER 14 0.0014
134 DERMATITIS DIAPER 1 0.0014
135 DEVICE ELECTRICAL FINDING 1 0.0014
136 EYE ROLLING 1 0.0014
137 C-REACTIVE PROTEIN ABNORMAL 9 0.0014
138 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 10 0.0014
139 BLOOD BILIRUBIN UNCONJUGATED INCREASED 1 0.0014
140 HYPOVOLAEMIA 8 0.0014
141 FIBROCYSTIC BREAST DISEASE 1 0.0014
142 ORAL MUCOSAL EXFOLIATION 2 0.0013
143 ERYTHEMA MULTIFORME 12 0.0013
144 INFECTION PARASITIC 1 0.0013
145 COMPULSIVE SEXUAL BEHAVIOUR 1 0.0012
146 COSTOCHONDRITIS 2 0.0012
147 DEVELOPMENTAL HIP DYSPLASIA 1 0.0012
148 CHEMICAL BURN OF SKIN 3 0.0012
149 JOINT STIFFNESS 31 0.0012
150 SKIN WOUND 2 0.0012
151 CYSTOCELE 1 0.0012
152 FOOD REFUSAL 1 0.0011
153 KYPHOSIS 2 0.0011
154 BLOOD ALBUMIN INCREASED 1 0.0011
155 BLOOD ALKALINE PHOSPHATASE ABNORMAL 1 0.0011
156 OROPHARYNGEAL DISCOMFORT 10 0.0011
157 INJECTION SITE DRYNESS 1 0.0011
158 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 7 0.0011
159 LIVE BIRTH 9 0.0011
160 BONE CYST 1 0.0011
161 SCIATICA 17 0.0011
162 MYELOPATHY 2 0.0011
163 HYPERTONIA 6 0.0010
164 IMPAIRED HEALING 34 0.0010
165 ULCER HAEMORRHAGE 7 0.0010
166 KNEE ARTHROPLASTY 21 0.0010
167 REBOUND ACID HYPERSECRETION 3 0.0010
168 LIP DRY 9 0.0010
169 HYPOCHROMIC ANAEMIA 1 0.0010
170 EXOSTOSIS 9 0.0010
171 FIBROSIS 3 0.0010
172 IMPULSE-CONTROL DISORDER 2 0.0010
173 DERMATITIS BULLOUS 7 0.0010
174 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 2 0.0010
175 FOETAL DEATH 5 0.0010
176 FOLLICULITIS 10 0.0010
177 IRIDOCYCLITIS 3 0.0009
178 FIBROMYALGIA 23 0.0009
179 BONE DEMINERALISATION 1 0.0009
180 BLOOD SODIUM ABNORMAL 1 0.0009
181 CATHETER SITE ERYTHEMA 2 0.0009
182 PRESCRIBED OVERDOSE 18 0.0009
183 APPLICATION SITE VESICLES 6 0.0009
184 PERIODONTITIS 2 0.0009
185 FACET JOINT SYNDROME 3 0.0009
186 GASTROINTESTINAL TRACT IRRITATION 1 0.0009
187 LIMB MASS 2 0.0009
188 DIABETIC NEPHROPATHY 2 0.0009
189 ELECTROCARDIOGRAM T WAVE INVERSION 2 0.0009
190 RESPIRATORY RATE INCREASED 8 0.0009
191 NEPHRITIS 3 0.0009
192 ESSENTIAL TREMOR 1 0.0009
193 DISLOCATION OF VERTEBRA 2 0.0009
194 CENTRAL NERVOUS SYSTEM INFECTION 1 0.0009
195 ALLODYNIA 1 0.0009
196 BRONCHOSPASM 12 0.0008
197 LIP SWELLING 28 0.0008
198 OXYGEN CONSUMPTION INCREASED 2 0.0008
199 C-REACTIVE PROTEIN INCREASED 30 0.0008
200 END STAGE RENAL DISEASE 15 0.0008
201 BREATH ODOUR 2 0.0008
202 INFUSION SITE WARMTH 1 0.0008
203 INTRA-ABDOMINAL HAEMATOMA 1 0.0008
204 NEURODERMATITIS 3 0.0008
205 BLOOD CALCIUM DECREASED 9 0.0008
206 PEMPHIGUS 10 0.0008
207 APPLICATION SITE SCAR 1 0.0008
208 CATHETER SITE HAEMORRHAGE 2 0.0008
209 CHRONIC SINUSITIS 3 0.0008
210 PEMPHIGOID 6 0.0008
211 APPLICATION SITE WARMTH 1 0.0008
212 LUPUS-LIKE SYNDROME 7 0.0008
213 RHINOVIRUS INFECTION 3 0.0008
214 SPINAL CORD COMPRESSION 3 0.0008
215 ORAL INFECTION 3 0.0008
216 MULTIPLE ALLERGIES 6 0.0008
217 HAND DEFORMITY 10 0.0008
218 LUNG OPACITY 2 0.0008
219 WALKING AID USER 5 0.0008
220 HALLUCINATION, VISUAL 16 0.0008
221 GASTROENTERITIS NOROVIRUS 1 0.0008
222 HIRSUTISM 1 0.0008
223 AREFLEXIA 2 0.0007
224 ANION GAP INCREASED 1 0.0007
225 INTERNATIONAL NORMALISED RATIO DECREASED 3 0.0007
226 INFUSION RELATED REACTION 49 0.0007
227 CLUSTER HEADACHE 1 0.0007
228 APPLICATION SITE INFLAMMATION 1 0.0007
229 DISCHARGE 1 0.0007
230 SYNOVITIS 13 0.0007
231 INCISIONAL HERNIA 1 0.0007
232 H1N1 INFLUENZA 1 0.0007
233 INTENSIVE CARE 1 0.0007
234 HYPERTONIC BLADDER 2 0.0007
235 PULMONARY PAIN 2 0.0007
236 AUTONOMIC NERVOUS SYSTEM IMBALANCE 2 0.0007
237 PULMONARY FIBROSIS 13 0.0007
238 METABOLIC ENCEPHALOPATHY 2 0.0007
239 EPICONDYLITIS 1 0.0007
240 PERICARDITIS 11 0.0007
241 TYPE 2 DIABETES MELLITUS 22 0.0007
242 DAYDREAMING 1 0.0006
243 PRE-EXISTING CONDITION IMPROVED 4 0.0006
244 BLOOD BLISTER 2 0.0006
245 RESPIRATORY RATE DECREASED 2 0.0006
246 FUNGAEMIA 1 0.0006
247 RED BLOOD CELL SEDIMENTATION RATE INCREASED 7 0.0006
248 FOOT DEFORMITY 7 0.0006
249 PNEUMONIA VIRAL 2 0.0006
250 RASH VESICULAR 3 0.0006
251 HYPOVENTILATION 2 0.0006
252 OSTEOARTHRITIS 26 0.0006
253 COELIAC DISEASE 6 0.0006
254 LIVER INJURY 15 0.0006
255 BLOOD CALCIUM ABNORMAL 1 0.0006
256 BLOOD CHOLESTEROL INCREASED 28 0.0006
257 ERYSIPELAS 3 0.0006
258 TUBULOINTERSTITIAL NEPHRITIS 11 0.0006
259 HAEMATOMA 15 0.0006
260 INFUSION SITE DISCHARGE 1 0.0006
261 BRONCHIOLITIS 2 0.0006
262 APPLICATION SITE DISCOMFORT 1 0.0006
263 PRESCRIBED UNDERDOSE 11 0.0006
264 HYPERSEXUALITY 1 0.0005
265 ESSENTIAL HYPERTENSION 1 0.0005
266 CONDUCTION DISORDER 1 0.0005
267 LOWER GASTROINTESTINAL HAEMORRHAGE 4 0.0005
268 TENDON INJURY 2 0.0005
269 THERAPEUTIC PRODUCT EFFECT DECREASED 24 0.0005
270 MATERNAL EXPOSURE TIMING UNSPECIFIED 2 0.0005
271 JAUNDICE NEONATAL 1 0.0005
272 HYPERCOAGULATION 1 0.0005
273 ARTERIAL DISORDER 1 0.0005
274 LOWER LIMB FRACTURE 10 0.0005
275 HEPATIC MASS 1 0.0005
276 FOOD ALLERGY 4 0.0005
277 EARLY SATIETY 1 0.0005
278 APNOEA 4 0.0005
279 PRODUCT ADMINISTRATION INTERRUPTED 4 0.0005
280 HYPOTHERMIA 5 0.0005
281 DECUBITUS ULCER 4 0.0005
282 COMPULSIVE SHOPPING 1 0.0005
283 SPINAL STENOSIS 2 0.0005
284 INJURY 34 0.0005
285 INTERNATIONAL NORMALISED RATIO FLUCTUATION 1 0.0005
286 CHEST INJURY 1 0.0005
287 MULTIPLE INJURIES 3 0.0005
288 ABSCESS LIMB 2 0.0005
289 HYPERPHOSPHATAEMIA 1 0.0005
290 APPLICATION SITE SCAB 1 0.0005
291 INFUSION SITE BRUISING 1 0.0005
292 ATRIOVENTRICULAR BLOCK FIRST DEGREE 2 0.0005
293 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 1 0.0005
294 TUMOUR LYSIS SYNDROME 4 0.0005
295 ENDOMETRIAL CANCER 1 0.0005
296 GRIP STRENGTH DECREASED 4 0.0005
297 CLOSTRIDIUM TEST POSITIVE 1 0.0005
298 FAECES PALE 1 0.0004
299 SINUSITIS 46 0.0004
300 POST-TRAUMATIC STRESS DISORDER 3 0.0004
301 GLOSSODYNIA 10 0.0004
302 APPLICATION SITE URTICARIA 1 0.0004
303 DISTRIBUTIVE SHOCK 1 0.0004
304 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 3 0.0004
305 LOWER RESPIRATORY TRACT INFECTION 20 0.0004
306 ECCHYMOSIS 3 0.0004
307 DYSURIA 16 0.0004
308 CHRONIC KIDNEY DISEASE 33 0.0004
309 EYELID DISORDER 1 0.0004
310 APHTHOUS STOMATITIS 1 0.0004
311 PERSONALITY CHANGE 4 0.0004
312 CONTRAINDICATED PRODUCT ADMINISTERED 13 0.0004
313 WOUND 12 0.0004
314 NEPHROPATHY 4 0.0004
315 NASAL CONGESTION 25 0.0004
316 VAGINAL INFECTION 2 0.0004
317 PHOTOSENSITIVITY REACTION 7 0.0004
318 SKIN ABRASION 2 0.0004
319 INFECTION 61 0.0004
320 ATELECTASIS 4 0.0004
321 SEPTIC SHOCK 18 0.0004
322 BURSITIS 5 0.0004
323 HEPATIC ENZYME INCREASED 28 0.0004
324 BLOOD PRESSURE SYSTOLIC INCREASED 8 0.0004
325 PHARYNGEAL SWELLING 4 0.0004
326 HYPONATRAEMIA 23 0.0004
327 EYE OEDEMA 1 0.0004
328 HEPARIN-INDUCED THROMBOCYTOPENIA 2 0.0004
329 RASH MACULO-PAPULAR 9 0.0004
330 DRUG INTOLERANCE 39 0.0004
331 IMMUNODEFICIENCY 6 0.0004
332 HYPERNATRAEMIA 2 0.0004
333 DIABETES MELLITUS INADEQUATE CONTROL 7 0.0004
334 ENDODONTIC PROCEDURE 1 0.0004
335 DRUG ADMINISTRATION ERROR 12 0.0004
336 MUSCLE TWITCHING 9 0.0004
337 FAILURE TO THRIVE 2 0.0004
338 NERVOUSNESS 20 0.0004
339 PARTIAL SEIZURES 2 0.0004
340 EXFOLIATIVE RASH 1 0.0004
341 EAR INFECTION 10 0.0004
342 ANIMAL BITE 1 0.0004
343 BLISTER 21 0.0004
344 ABDOMINAL MASS 1 0.0004
345 HEPATIC CIRRHOSIS 7 0.0004
346 OVERWEIGHT 2 0.0004
347 LOCALISED INFECTION 9 0.0004
348 ANAL ABSCESS 2 0.0004
349 GINGIVITIS 2 0.0004
350 GAMBLING DISORDER 1 0.0004
351 CHONDROPATHY 1 0.0004
352 HYDROCEPHALUS 2 0.0004
353 WOUND INFECTION 4 0.0004
354 SPINAL COMPRESSION FRACTURE 3 0.0004
355 ENDOTRACHEAL INTUBATION 1 0.0004
356 THERAPY NON-RESPONDER 16 0.0004
357 SEASONAL ALLERGY 5 0.0004
358 MULTIPLE ORGAN DYSFUNCTION SYNDROME 10 0.0004
359 PERONEAL NERVE PALSY 2 0.0004
360 TREATMENT FAILURE 29 0.0003
361 FINE MOTOR SKILL DYSFUNCTION 1 0.0003
362 RESPIRATORY SYNCYTIAL VIRUS INFECTION 3 0.0003
363 SEDATION 9 0.0003
364 BLOOD PARATHYROID HORMONE INCREASED 1 0.0003
365 INTENTIONAL PRODUCT USE ISSUE 30 0.0003
366 SPINAL OSTEOARTHRITIS 3 0.0003
367 SYSTEMIC LUPUS ERYTHEMATOSUS 12 0.0003
368 SINUS HEADACHE 2 0.0003
369 INFUSION SITE REACTION 1 0.0003
370 HYPOAESTHESIA 50 0.0003
371 BONE MARROW DISORDER 1 0.0003
372 CRANIOCEREBRAL INJURY 1 0.0003
373 EMERGENCY CARE 1 0.0003
374 EMBOLISM VENOUS 1 0.0003
375 NOCTURIA 4 0.0003
376 KERATITIS 1 0.0003
377 ISCHAEMIC CARDIOMYOPATHY 1 0.0003
378 RHINORRHOEA 21 0.0003
379 BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0003
380 OROPHARYNGEAL PAIN 30 0.0003
381 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 2 0.0003
382 URTICARIA 54 0.0003
383 NASAL DRYNESS 2 0.0003
384 DERMATITIS ALLERGIC 4 0.0003
385 APPLICATION SITE PAIN 7 0.0003
386 BLEPHAROSPASM 2 0.0003
387 FOREIGN BODY IN THROAT 1 0.0003
388 INFUSION SITE PRURITUS 1 0.0003
389 DRUG EFFECT INCREASED 1 0.0003
390 SEROTONIN SYNDROME 6 0.0003
391 CONTUSION 30 0.0003
392 BREAST CANCER STAGE III 2 0.0003
393 SINUS DISORDER 6 0.0003
394 HYPERSENSITIVITY 56 0.0003
395 FEBRILE NEUTROPENIA 20 0.0003
396 ANXIETY DISORDER 1 0.0003
397 BLOOD POTASSIUM DECREASED 9 0.0003
398 GAIT INABILITY 10 0.0003
399 CYTOKINE RELEASE SYNDROME 6 0.0003
400 PSORIATIC ARTHROPATHY 12 0.0003
401 DRY THROAT 3 0.0003
402 HEPATIC CYST 1 0.0003
403 ABNORMAL LOSS OF WEIGHT 2 0.0003
404 MATERNAL EXPOSURE BEFORE PREGNANCY 2 0.0003
405 HYPERTENSION 62 0.0003
406 MOBILITY DECREASED 21 0.0003
407 ASTHMA 33 0.0003
408 HEPATIC FIBROSIS 1 0.0003
409 LEFT VENTRICULAR FAILURE 1 0.0003
410 BLOOD CREATININE ABNORMAL 1 0.0003
411 GRANULOMA 1 0.0003
412 HYPERTRANSAMINASAEMIA 2 0.0003
413 ACUTE KIDNEY INJURY 44 0.0003
414 FORMICATION 2 0.0003
415 RIGHT VENTRICULAR FAILURE 2 0.0003
416 EAR PRURITUS 1 0.0003
417 EMBOLIC STROKE 1 0.0003
418 INCONTINENCE 3 0.0003
419 DUODENAL ULCER 2 0.0003
420 DRY MOUTH 23 0.0003
421 GLOSSITIS 1 0.0003
422 RETINAL HAEMORRHAGE 2 0.0003
423 RECTAL HAEMORRHAGE 12 0.0003
424 NIGHT SWEATS 9 0.0003
425 LEUKOCYTOSIS 5 0.0003
426 DENTAL CARIES 3 0.0003
427 PSYCHIATRIC SYMPTOM 2 0.0003
428 HYPOPHOSPHATAEMIA 2 0.0003
429 HYPERACUSIS 1 0.0003
430 SWELLING 25 0.0003
431 GASTRITIS 7 0.0003
432 HYPOCALCAEMIA 5 0.0003
433 FRACTURE 5 0.0003
434 SCAB 3 0.0003
435 TROPONIN INCREASED 2 0.0003
436 ILLNESS 27 0.0003
437 INSURANCE ISSUE 4 0.0003
438 SKIN DISCOLOURATION 12 0.0003
439 CLAVICLE FRACTURE 1 0.0003
440 NASOPHARYNGITIS 48 0.0003
441 INFLUENZA 29 0.0003
442 HYPOKALAEMIA 12 0.0003
443 UPPER RESPIRATORY TRACT INFECTION 12 0.0003
444 FEMUR FRACTURE 8 0.0003
445 ERYTHEMA 53 0.0003
446 DISABILITY 5 0.0003
447 BACTERAEMIA 3 0.0003
448 ATAXIA 3 0.0003
449 MIGRAINE 24 0.0003
450 PREGNANCY 5 0.0002
451 ADVERSE EVENT 23 0.0002
452 OXYGEN SATURATION DECREASED 14 0.0002
453 FEEDING DISORDER 5 0.0002
454 APPLICATION SITE DISCOLOURATION 1 0.0002
455 LUNG DISORDER 12 0.0002
456 ARTHRITIS BACTERIAL 1 0.0002
457 HYPERURICAEMIA 1 0.0002
458 OSTEOPOROSIS 10 0.0002
459 CONGESTIVE CARDIOMYOPATHY 1 0.0002
460 ROAD TRAFFIC ACCIDENT 10 0.0002
461 CHILLS 28 0.0002
462 HAEMODIALYSIS 2 0.0002
463 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1 0.0002
464 ACUTE MYOCARDIAL INFARCTION 7 0.0002
465 SENSATION OF FOREIGN BODY 2 0.0002
466 COUGH 66 0.0002
467 INTERVERTEBRAL DISC DISORDER 1 0.0002
468 ALCOHOLISM 1 0.0002
469 RENAL FAILURE 31 0.0002
470 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 4 0.0002
471 PSEUDOMONAS INFECTION 2 0.0002
472 LIVER FUNCTION TEST INCREASED 5 0.0002
473 INFUSION SITE PAIN 3 0.0002
474 ORTHOSTATIC HYPOTENSION 4 0.0002
475 VERTIGO 14 0.0002
476 MUSCULOSKELETAL PAIN 12 0.0002
477 CYTOMEGALOVIRUS INFECTION REACTIVATION 1 0.0002
478 LIGAMENT RUPTURE 1 0.0002
479 BLOOD CREATINE INCREASED 1 0.0002
480 DRUG ERUPTION 4 0.0002
481 STEVENS-JOHNSON SYNDROME 5 0.0002
482 BACK PAIN 52 0.0002
483 JAUNDICE 6 0.0002
484 OEDEMA 12 0.0002
485 UVEITIS 3 0.0002
486 OSTEOMYELITIS 4 0.0002
487 DRUG EFFECT DELAYED 1 0.0002
488 EAR DISORDER 1 0.0002
489 INJECTION SITE REACTION 15 0.0002
490 ISCHAEMIA 1 0.0002
491 NERVE COMPRESSION 2 0.0002
492 BLOOD CHOLESTEROL ABNORMAL 1 0.0002
493 ARTHROPATHY 12 0.0002
494 BREAST CANCER STAGE I 2 0.0002
495 HYPOMAGNESAEMIA 3 0.0002
496 FEELING OF DESPAIR 1 0.0002
497 LACERATION 2 0.0002
498 ARTERIOSCLEROSIS 2 0.0002
499 DECREASED APPETITE 49 0.0002
500 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 11 0.0002
501 PROTEINURIA 4 0.0002
502 GESTATIONAL DIABETES 1 0.0002
503 HYPOVOLAEMIC SHOCK 1 0.0002
504 GASTROINTESTINAL TOXICITY 1 0.0002
505 SINUS BRADYCARDIA 2 0.0002
506 COMPLICATION ASSOCIATED WITH DEVICE 3 0.0002
507 FINGER DEFORMITY 1 0.0002
508 LIVER FUNCTION TEST ABNORMAL 6 0.0002
509 EAR PAIN 4 0.0002
510 HAEMORRHOIDS 4 0.0002
511 HAEMATURIA 7 0.0002
512 DECREASED IMMUNE RESPONSIVENESS 2 0.0002
513 BODY TEMPERATURE DECREASED 2 0.0002
514 HYPERVOLAEMIA 1 0.0002
515 DIABETIC NEUROPATHY 1 0.0002
516 ABDOMINAL TENDERNESS 1 0.0002
517 APPLICATION SITE SWELLING 1 0.0002
518 INJECTION SITE BRUISING 16 0.0002
519 ADVERSE DRUG REACTION 18 0.0002
520 PRURITUS 77 0.0002
521 MYALGIA 34 0.0002
522 HYPOTENSION 40 0.0002
523 GENERAL PHYSICAL HEALTH DETERIORATION 23 0.0002
524 OSTEOPENIA 3 0.0002
525 ABDOMINAL DISCOMFORT 33 0.0002
526 ENDOCARDITIS 1 0.0002
527 INCREASED UPPER AIRWAY SECRETION 1 0.0002
528 EJECTION FRACTION DECREASED 3 0.0002
529 VENTRICULAR EXTRASYSTOLES 2 0.0002
530 THERAPY PARTIAL RESPONDER 3 0.0002
531 PULMONARY HYPERTENSION 4 0.0002
532 TENDERNESS 2 0.0002
533 TRANSFUSION 2 0.0002
534 BLOOD LACTIC ACID INCREASED 1 0.0002
535 OBESITY 3 0.0002
536 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
537 FOOD POISONING 1 0.0002
538 COMPRESSION FRACTURE 1 0.0002
539 BEHAVIOUR DISORDER 1 0.0002
540 RASH PRURITIC 10 0.0002
541 SWELLING FACE 12 0.0002
542 SLEEP DISORDER 13 0.0002
543 SKIN LACERATION 2 0.0002
544 PULMONARY THROMBOSIS 2 0.0002
545 GASTROINTESTINAL PAIN 2 0.0002
546 MENTAL STATUS CHANGES 5 0.0002
547 FUNGAL INFECTION 6 0.0002
548 NERVE INJURY 2 0.0002
549 CELLULITIS 9 0.0002
550 FACE OEDEMA 3 0.0002
551 CHROMATURIA 4 0.0002
552 CIRCULATORY COLLAPSE 3 0.0002
553 GENERALISED ERYTHEMA 1 0.0002
554 SCAR 3 0.0002
555 MICTURITION URGENCY 2 0.0002
556 JOINT SWELLING 21 0.0002
557 GASTROOESOPHAGEAL REFLUX DISEASE 14 0.0002
558 HALLUCINATION 13 0.0002
559 MUSCULOSKELETAL STIFFNESS 15 0.0002
560 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 1 0.0002
561 WHEEZING 10 0.0002
562 MATERNAL EXPOSURE DURING PREGNANCY 15 0.0002
563 THIRST 3 0.0002
564 ACCIDENT 2 0.0002
565 HYPERLIPIDAEMIA 2 0.0002
566 MUSCULAR WEAKNESS 19 0.0002
567 CONFUSIONAL STATE 27 0.0002
568 STOMATITIS 10 0.0002
569 NEURALGIA 4 0.0002
570 INGUINAL HERNIA 1 0.0002
571 DISCOMFORT 10 0.0002
572 CYTOPENIA 2 0.0002
573 CARDIOMEGALY 2 0.0002
574 CONJUNCTIVITIS 3 0.0002
575 APPLICATION SITE IRRITATION 2 0.0002
576 PNEUMONIA ASPIRATION 4 0.0002
577 DRUG-INDUCED LIVER INJURY 5 0.0002
578 INFUSION SITE SWELLING 1 0.0002
579 BRAIN OEDEMA 2 0.0002
580 FOOT FRACTURE 3 0.0002
581 ANGIOEDEMA 7 0.0002
582 ALOPECIA 31 0.0002
583 DRUG INTERACTION 25 0.0002
584 SLEEP APNOEA SYNDROME 3 0.0002
585 FOREIGN BODY SENSATION IN EYES 1 0.0002
586 CHEST PAIN 29 0.0002
587 ENTERITIS 1 0.0002
588 ACUTE RESPIRATORY FAILURE 3 0.0002
589 HAEMOGLOBIN ABNORMAL 1 0.0002
590 INFLAMMATION 8 0.0002
591 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 11 0.0002
592 INCOHERENT 1 0.0002
593 PNEUMONIA 50 0.0002
594 HERPES SIMPLEX 1 0.0002
595 DYSPEPSIA 15 0.0002
596 SEPSIS 17 0.0002
597 SARS-COV-2 TEST POSITIVE 2 0.0002
598 DISORIENTATION 6 0.0002
599 CONDITION AGGRAVATED 46 0.0002
600 RHEUMATOID ARTHRITIS 17 0.0001
601 DYSPNOEA 84 0.0001
602 COLITIS ISCHAEMIC 1 0.0001
603 ILL-DEFINED DISORDER 9 0.0001
604 SINUS CONGESTION 2 0.0001
605 TASTE DISORDER 3 0.0001
606 LIMB INJURY 4 0.0001
607 DISEASE RECURRENCE 7 0.0001
608 TACHYPNOEA 2 0.0001
609 IMPAIRED GASTRIC EMPTYING 2 0.0001
610 RASH ERYTHEMATOUS 7 0.0001
611 RIB FRACTURE 3 0.0001
612 ANAPHYLACTIC REACTION 8 0.0001
613 DROOLING 1 0.0001
614 TOOTH LOSS 3 0.0001
615 HUNGER 2 0.0001
616 APPLICATION SITE REACTION 1 0.0001
617 SKIN REACTION 2 0.0001
618 DIALYSIS 2 0.0001
619 SINUS TACHYCARDIA 2 0.0001
620 RETCHING 3 0.0001
621 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0001
622 IMPAIRED QUALITY OF LIFE 2 0.0001
623 GRAFT VERSUS HOST DISEASE 1 0.0001
624 INSOMNIA 37 0.0001
625 ALTERED STATE OF CONSCIOUSNESS 3 0.0001
626 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
627 ANAEMIA 26 0.0001
628 MELAENA 3 0.0001
629 LIVER DISORDER 6 0.0001
630 BRONCHITIS 10 0.0001
631 URINARY INCONTINENCE 4 0.0001
632 HEPATOTOXICITY 3 0.0001
633 RENAL INJURY 4 0.0001
634 DIZZINESS 67 0.0001
635 PULMONARY MASS 2 0.0001
636 ORAL PAIN 3 0.0001
637 THROAT IRRITATION 6 0.0001
638 HYDRONEPHROSIS 1 0.0001
639 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 1 0.0001
640 PRODUCT USE IN UNAPPROVED INDICATION 33 0.0001
641 DYSPNOEA EXERTIONAL 5 0.0001
642 ECONOMIC PROBLEM 2 0.0001
643 COLITIS 5 0.0001
644 OEDEMA PERIPHERAL 16 0.0001
645 PAIN 80 0.0001
646 TENDONITIS 2 0.0001
647 HYPOALBUMINAEMIA 1 0.0001
648 DEVICE INFORMATION OUTPUT ISSUE 1 0.0001
649 SWOLLEN TONGUE 4 0.0001
650 BRAIN FOG 2 0.0001
651 BALANCE DISORDER 11 0.0001
652 HEAD INJURY 4 0.0001
653 FURUNCLE 1 0.0001
654 PNEUMOTHORAX 2 0.0001
655 BLOOD ALBUMIN DECREASED 1 0.0001
656 PRODUCTIVE COUGH 6 0.0001
657 BLOOD DISORDER 1 0.0001
658 HIP FRACTURE 4 0.0001
659 TACHYCARDIA 11 0.0001
660 RESPIRATORY FAILURE 9 0.0001
661 BLOOD POTASSIUM INCREASED 2 0.0001
662 BACK DISORDER 2 0.0001
663 ARTHRALGIA 51 0.0001
664 OFF LABEL USE 107 0.0001
665 HICCUPS 1 0.0001
666 HEART RATE INCREASED 12 0.0001
667 VISUAL IMPAIRMENT 15 0.0001
668 EMBOLISM 1 0.0001
669 HEMIPLEGIA 1 0.0001
670 COAGULOPATHY 2 0.0001
671 POLLAKIURIA 5 0.0001
672 BLOOD UREA INCREASED 2 0.0001
673 ATRIAL SEPTAL DEFECT 1 0.0001
674 UPPER GASTROINTESTINAL HAEMORRHAGE 2 0.0001
675 INFUSION SITE ERYTHEMA 1 0.0001
676 FLUID RETENTION 6 0.0001
677 PRODUCT USE ISSUE 22 0.0001
678 PERIPHERAL SWELLING 18 0.0001
679 VISION BLURRED 16 0.0001
680 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 21 0.0001
681 HEADACHE 73 0.0001
682 MUSCULOSKELETAL DISCOMFORT 2 0.0001
683 NEUROPATHY PERIPHERAL 11 0.0001
684 THERAPEUTIC RESPONSE DECREASED 7 0.0001
685 DELIRIUM 4 0.0001
686 VAGINAL HAEMORRHAGE 5 0.0001
687 APPLICATION SITE ERYTHEMA 3 0.0001
688 RASH MACULAR 4 0.0001
689 ANHEDONIA 3 0.0001
690 HYPERKALAEMIA 4 0.0001
691 AMENORRHOEA 2 0.0001
692 BLOOD CALCIUM INCREASED 1 0.0001
693 HYPOXIA 4 0.0001
694 LYMPHOCYTE COUNT DECREASED 2 0.0001
695 GASTROINTESTINAL DISORDER 10 0.0001
696 GASTROINTESTINAL INFECTION 1 0.0001
697 PALLOR 3 0.0001
698 RASH 48 0.0001
699 PELVIC PAIN 2 0.0001
700 HYPERGLYCAEMIA 4 0.0001
701 BONE DISORDER 2 0.0001
702 NEPHROLITHIASIS 5 0.0001
703 RESPIRATORY DISTRESS 3 0.0001
704 IRON DEFICIENCY ANAEMIA 1 0.0001
705 GRAND MAL CONVULSION 1 0.0001
706 COVID-19 19 0.0001
707 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
708 FATIGUE 84 0.0001
709 NECK PAIN 6 0.0001
710 BACTERIAL INFECTION 2 0.0001
711 DEFORMITY 1 0.0001
712 SKIN EXFOLIATION 9 0.0001
713 COMA 5 0.0001
714 ANGINA PECTORIS 3 0.0001
715 WHITE BLOOD CELL COUNT INCREASED 4 0.0001
716 BLOOD CREATINE PHOSPHOKINASE INCREASED 3 0.0001
717 PYREXIA 36 0.0001
718 HERNIA 2 0.0001
719 ARTHRITIS 8 0.0001
720 KNEE OPERATION 1 0.0001
721 HOSPICE CARE 1 0.0001
722 HAEMATOCRIT DECREASED 2 0.0001
723 HYPOTONIA 1 0.0001
724 URINARY TRACT INFECTION 17 0.0001
725 THROMBOCYTOPENIA 11 0.0001
726 BLINDNESS 4 0.0001
727 EUPHORIC MOOD 1 0.0001
728 EAR DISCOMFORT 1 0.0001
729 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 1 0.0001
730 PERITONITIS 2 0.0001
731 HYPERBILIRUBINAEMIA 1 0.0001
732 EXPOSURE DURING PREGNANCY 6 0.0001
733 FALL 32 0.0001
734 RENAL IMPAIRMENT 8 0.0001
735 DRUG ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
736 SOMNOLENCE 19 0.0001
737 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
738 EATING DISORDER 2 0.0001
739 BREAST PAIN 1 0.0001
740 JOINT INJURY 2 0.0001
741 ATRIAL FIBRILLATION 9 0.0001
742 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
743 BIPOLAR DISORDER 1 0.0001
744 BACK INJURY 1 0.0001
745 BLOOD CREATININE INCREASED 6 0.0001
746 ASPIRATION 1 0.0001
747 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 5 0.0001
748 SYNCOPE 9 0.0001
749 TRANSAMINASES INCREASED 2 0.0001
750 TOOTH DISORDER 2 0.0001
751 PULMONARY OEDEMA 4 0.0001
752 RASH PAPULAR 2 0.0001
753 SNEEZING 2 0.0001
754 THERAPEUTIC RESPONSE UNEXPECTED 4 0.0001
755 FISTULA 1 0.0001
756 TRANSIENT ISCHAEMIC ATTACK 3 0.0001
757 EYE INFECTION 1 0.0001
758 DIARRHOEA 57 0.0001
759 IMPAIRED DRIVING ABILITY 1 0.0001
760 CHOLECYSTECTOMY 1 0.0001
761 INTERNAL HAEMORRHAGE 1 0.0001
762 ELECTROLYTE IMBALANCE 1 0.0001
763 ABDOMINAL PAIN 20 0.0001
764 BURNING SENSATION 6 0.0001
765 PALPITATIONS 10 0.0001
766 PAIN IN EXTREMITY 25 0.0001
767 COVID-19 PNEUMONIA 1 0.0001
768 PLATELET COUNT DECREASED 9 0.0001
769 BLOOD IRON DECREASED 1 0.0001
770 BLOOD PRESSURE FLUCTUATION 2 0.0001
771 RESTLESSNESS 3 0.0001
772 AGITATION 6 0.0001
773 ENCEPHALOPATHY 2 0.0001
774 HYPERCALCAEMIA 1 0.0001
775 OSTEONECROSIS OF JAW 2 0.0001
776 ANXIETY 23 0.0001
777 GENERALISED OEDEMA 1 0.0001
778 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
779 ILEUS 1 0.0001
780 INTENTIONAL PRODUCT MISUSE 7 0.0001
781 AGGRESSION 4 0.0001
782 HOT FLUSH 6 0.0001
783 INTESTINAL OBSTRUCTION 3 0.0001
784 ABDOMINAL PAIN LOWER 2 0.0001
785 HAEMATEMESIS 2 0.0001
786 HYPOPHAGIA 2 0.0001
787 HEPATITIS 2 0.0001
788 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2 0.0001
789 ABDOMINAL PAIN UPPER 16 0.0001
790 HIATUS HERNIA 1 0.0001
791 ASTHENIA 29 0.0001
792 DIPLOPIA 2 0.0001
793 VOMITING 36 0.0001
794 SUICIDAL IDEATION 7 0.0001
795 MUCOSAL INFLAMMATION 2 0.0001
796 ADVERSE REACTION 1 0.0001
797 DEHYDRATION 10 0.0001
798 NEOPLASM MALIGNANT 5 0.0001
799 DEPRESSION 17 0.0001
800 BLOOD BILIRUBIN INCREASED 2 0.0001
801 DEVICE MECHANICAL ISSUE 1 0.0001
802 CORONARY ARTERY OCCLUSION 1 0.0001
803 MEMORY IMPAIRMENT 10 0.0001
804 APPLICATION SITE RASH 1 0.0001
805 PROCEDURAL PAIN 2 0.0001
806 MEDICATION ERROR 4 0.0001
807 BLOOD PRESSURE INCREASED 11 0.0001
808 CARDIO-RESPIRATORY ARREST 3 0.0001
809 HAEMOPTYSIS 2 0.0001
810 COORDINATION ABNORMAL 1 0.0001
811 APHONIA 1 0.0001
812 CARPAL TUNNEL SYNDROME 1 0.0001
813 INCORRECT DRUG ADMINISTRATION DURATION 2 0.0001
814 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
815 PRODUCT DOSE OMISSION IN ERROR 2 0.0001
816 PAIN IN JAW 2 0.0001
817 LOSS OF CONSCIOUSNESS 9 0.0001
818 INTENTIONAL DOSE OMISSION 2 0.0001
819 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
820 SKIN BURNING SENSATION 5 0.0001
821 HYPERSOMNIA 2 0.0001
822 FLUSHING 7 0.0001
823 APATHY 1 0.0001
824 GASTROENTERITIS 1 0.0001
825 DYSPHONIA 4 0.0001
826 SURGERY 4 0.0001
827 ASCITES 2 0.0001
828 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
829 RESPIRATORY DISORDER 2 0.0001
830 IRRITABILITY 4 0.0001
831 HYPOAESTHESIA ORAL 1 0.0001
832 LACRIMATION INCREASED 2 0.0001
833 CORONARY ARTERY DISEASE 2 0.0001
834 PLEURAL EFFUSION 4 0.0001
835 SKIN IRRITATION 3 0.0001
836 EPILEPSY 2 0.0001
837 ALANINE AMINOTRANSFERASE INCREASED 4 0.0001
838 DEVICE RELATED INFECTION 1 0.0001
839 LIMB DISCOMFORT 2 0.0001
840 ANKLE FRACTURE 1 0.0001
841 DRUG INEFFECTIVE 85 0.0001
842 CONSTIPATION 14 0.0001
843 BONE DENSITY DECREASED 2 0.0001
844 MOOD SWINGS 2 0.0001
845 ABSCESS 1 0.0001
846 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3 0.0001
847 CARDIAC FAILURE 5 0.0001
848 HYPOGLYCAEMIA 3 0.0001
849 CHOLELITHIASIS 2 0.0001
850 NO ADVERSE EVENT 11 0.0001
851 CARDIAC ARREST 5 0.0001
852 EXPIRED PRODUCT ADMINISTERED 2 0.0001
853 DRY EYE 3 0.0001
854 LEUKOPENIA 3 0.0001
855 MUSCLE SPASMS 11 0.0001
856 URINARY RETENTION 2 0.0001
857 NAUSEA 47 0.0001
858 CHEST DISCOMFORT 6 0.0001
859 MALIGNANT NEOPLASM PROGRESSION 6 0.0001
860 EMOTIONAL DISTRESS 7 0.0001
861 NIGHTMARE 2 0.0001
862 ABDOMINAL DISTENSION 6 0.0001
863 SPEECH DISORDER 3 0.0001
864 EOSINOPHILIA 1 0.0001
865 DERMATITIS ATOPIC 3 0.0001
866 DEPRESSED MOOD 3 0.0001
867 COLD SWEAT 1 0.0001
868 BRADYCARDIA 3 0.0001
869 HEAD DISCOMFORT 1 0.0001
870 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 4 0.0001
871 GALLBLADDER DISORDER 1 0.0001
872 PRODUCT ADHESION ISSUE 2 0.0001
873 GOUT 1 0.0001
874 WRONG TECHNIQUE IN DRUG USAGE PROCESS 2 0.0001
875 UNDERDOSE 4 0.0001
876 ACCIDENTAL OVERDOSE 2 0.0001
877 HYPERHIDROSIS 7 0.0001
878 TREMOR 9 0.0001
879 BLOOD GLUCOSE ABNORMAL 1 0.0001
880 WEIGHT DECREASED 15 0.0001
881 HEPATIC STEATOSIS 1 0.0001
882 PSORIASIS 7 0.0001
883 EPISTAXIS 4 0.0001
884 FLATULENCE 3 0.0001
885 BLOOD URINE PRESENT 1 0.0001
886 MALAISE 23 0.0001
887 GAIT DISTURBANCE 10 0.0001
888 CHOLESTASIS 1 0.0001
889 DRUG PRESCRIBING ERROR 1 0.0001
890 ERUCTATION 1 0.0001
891 CHOKING 1 0.0001
892 BONE PAIN 3 0.0001
893 CATARACT 3 0.0001
894 BLOOD PRESSURE ABNORMAL 1 0.0001
895 CARDIAC FAILURE CONGESTIVE 4 0.0000
896 FULL BLOOD COUNT DECREASED 1 0.0000
897 DYSKINESIA 2 0.0000
898 FEELING HOT 3 0.0000
899 HAEMOGLOBIN DECREASED 5 0.0000
900 ACCIDENTAL EXPOSURE TO PRODUCT 5 0.0000
901 RHABDOMYOLYSIS 2 0.0000
902 INTENTIONAL DRUG MISUSE 1 0.0000
903 RENAL FAILURE ACUTE 2 0.0000
904 IMPAIRED WORK ABILITY 1 0.0000
905 WHITE BLOOD CELL COUNT DECREASED 5 0.0000
906 FAECES DISCOLOURED 1 0.0000
907 AMNESIA 3 0.0000
908 DEVICE DISLOCATION 2 0.0000
909 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
910 HOSPITALISATION 7 0.0000
911 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
912 PARAESTHESIA 7 0.0000
913 HEART RATE IRREGULAR 1 0.0000
914 PRODUCT QUALITY ISSUE 6 0.0000
915 NEUTROPENIA 6 0.0000
916 APPLICATION SITE PRURITUS 1 0.0000
917 INCORRECT DOSE ADMINISTERED 10 0.0000
918 TINNITUS 2 0.0000
919 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 2 0.0000
920 DYSPHAGIA 4 0.0000
921 FEELING ABNORMAL 10 0.0000
922 BLOOD GLUCOSE DECREASED 2 0.0000
923 DIABETIC KETOACIDOSIS 1 0.0000
924 ABASIA 1 0.0000
925 DYSGEUSIA 3 0.0000
926 EXTRAPYRAMIDAL DISORDER 1 0.0000
927 WEIGHT INCREASED 9 0.0000
928 UNEVALUABLE EVENT 3 0.0000
929 DIABETES MELLITUS 3 0.0000
930 DEAFNESS 1 0.0000
931 ECZEMA 2 0.0000
932 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
933 PRODUCT DOSE OMISSION ISSUE 11 0.0000
934 DISTURBANCE IN ATTENTION 2 0.0000
935 FREQUENT BOWEL MOVEMENTS 1 0.0000
936 TREATMENT NONCOMPLIANCE 2 0.0000
937 ABNORMAL DREAMS 1 0.0000
938 DIVERTICULITIS 1 0.0000
939 DRUG ABUSE 3 0.0000
940 FEELING COLD 1 0.0000
941 PANCYTOPENIA 2 0.0000
942 DEMENTIA 1 0.0000
943 CONVULSION 2 0.0000
944 DEATH 30 0.0000
945 HERPES ZOSTER 2 0.0000
946 PRODUCT SUBSTITUTION ISSUE 2 0.0000
947 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
948 HEPATIC FAILURE 1 0.0000
949 APHASIA 1 0.0000
950 INJECTION SITE RASH 1 0.0000
951 OVERDOSE 7 0.0000
952 EMOTIONAL DISORDER 1 0.0000
953 CARDIAC DISORDER 3 0.0000
954 PULMONARY EMBOLISM 3 0.0000
955 CYSTITIS 1 0.0000
956 HYPOTHYROIDISM 1 0.0000
957 EYE DISORDER 1 0.0000
958 EYE PRURITUS 1 0.0000
959 TOXICITY TO VARIOUS AGENTS 5 0.0000
960 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 6 0.0000
961 CEREBROVASCULAR ACCIDENT 5 0.0000
962 HEART RATE DECREASED 1 0.0000
963 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
964 CEREBRAL HAEMORRHAGE 1 0.0000
965 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
966 CRYING 1 0.0000
967 INJECTION SITE MASS 1 0.0000
968 INJECTION SITE SWELLING 2 0.0000
969 SEIZURE 3 0.0000
970 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
971 DRUG DEPENDENCE 4 0.0000
972 THROMBOSIS 2 0.0000
973 INJECTION SITE ERYTHEMA 3 0.0000
974 HYPOACUSIS 1 0.0000
975 DRY SKIN 3 0.0000
976 COLITIS ULCERATIVE 1 0.0000
977 BREAST CANCER 2 0.0000
978 COGNITIVE DISORDER 1 0.0000
979 ARRHYTHMIA 1 0.0000
980 DRUG EFFECT DECREASED 1 0.0000
981 HAEMATOCHEZIA 1 0.0000
982 EYE PAIN 1 0.0000
983 LETHARGY 1 0.0000
984 MYOCARDIAL INFARCTION 3 0.0000
985 DEVICE EXPULSION 1 0.0000
986 DEEP VEIN THROMBOSIS 1 0.0000
987 BLOOD PRESSURE DECREASED 1 0.0000
988 INJECTION SITE PRURITUS 1 0.0000
989 INJECTION SITE PAIN 4 0.0000
990 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
991 DEVICE ISSUE 1 0.0000
992 BLOOD GLUCOSE INCREASED 2 0.0000
993 DISEASE PROGRESSION 1 0.0000